CVE-2026-21923
CVE-2026-21923
Vexday Risk Score
13Low
SSVC decision (CISA)
Track
No exploitation signal → monitor
CVSS 6.5EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch referenciado
Lifecycle
20 Jan 2026Published on NVD
Recommendation: Monitor — no exploitation signal at the moment.
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Affected products
Oracle Corporation · Oracle Life Sciences Central Designer